ad1
- X4 Pharmaceuticals (NASDAQ:XFOR) is scheduled to announce Q4 earnings results on Tuesday, March 25th, before market open.
The consensus EPS Estimate is -$0.16 (-60.0% Y/Y) and the consensus Revenue Estimate is $1.06MOver the last 1 year, XFOR has beaten EPS estimates 50% of the time and has beaten revenue estimates 0% of the time.
More on X4 Pharmaceuticals
ad3
edu
edu
edu
edu
edu
